Company profile for Riparian Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Riparian Pharmaceuticals, Inc., is a privately held biotechnology company founded to discover drug targets and therapeutics that impact endothelial dysfunction and vascular inflammation. The company's therapeutics target new vasoprotective pathways to treat both prevalent and serious rare vascular diseases at an early stage, enabling physicians to have improved patient outcomes. Riparian has raised $6M in combined investment a...
Riparian Pharmaceuticals, Inc., is a privately held biotechnology company founded to discover drug targets and therapeutics that impact endothelial dysfunction and vascular inflammation. The company's therapeutics target new vasoprotective pathways to treat both prevalent and serious rare vascular diseases at an early stage, enabling physicians to have improved patient outcomes. Riparian has raised $6M in combined investment and research services from Viva Biotech Incubator and JMCR Partners, as well as support from research foundations including the National Institutes of Health and the Massachusetts Life Science Center.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
201 DEXTER AVENUE WATERTOWN, MA 02472
Telephone
Telephone
+1 6173987784
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/viva-biotechs-portfolio-company-riparian-pharmaceuticals-announces-exclusive-license-agreement-and-research-agreement-with-pfizer-for-novel-cardiovascular-programs-301882021.html

PR NEWSWIRE
20 Jul 2023

https://www.businesswire.com/news/home/20230719883190/en

BUSINESSWIRE
19 Jul 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty